GBM Model
Modeling Glioblastoma Multiforme Using Human Cerebral Organoids
Glioblastoma Multiforme (GBM) is the most aggressive primary brain tumor, defined not only by rapid proliferation but by its diffuse invasion into surrounding brain tissue. Traditional in vitro and animal models often fail to capture this invasive behavior in a human-relevant context.
This case study presents a cerebral organoid – based GBM model that enables the study of tumor invasion and tumor – brain interactions within a 3D human brain – like microenvironment.
Challenges
GBM research continues to be limited by models that fail to capture key disease features, including the loss of invasive tumor behavior in 2D cultures and species mismatch in animal studies. Current systems also inadequately represent tumor–neuron and tumor–glia interactions, contributing to the poor translatability of preclinical drug response data.
As a result, there is a clear need for models that reflect how GBM behaves within human brain tissue, rather than in isolation.
Modeling GBM with Cerebral Organoids
To address these challenges, human iPSC-derived cerebral organoids were used as a physiologically relevant brain-like scaffold and co-cultured with patient-derived GBM cells. Rather than modeling tumor initiation, this platform focuses on tumor progression and invasion in a human neural context.
Key features of the model:
3D human brain architecture
Cerebral organoids recapitulate key structural and cellular features of human brain tissue
Tumor–brain co-culture:
Patient-derived GBM cells interact directly with neuronal and glial networks
Invasion-focused modeling:
Enables analysis of diffuse GBM infiltration and migration patterns
Functional phenotypic readouts:
Supports quantitative assessment of invasion dynamics and drug response
Discuss Your GBM Research
Related Solutions
Glioblastoma Multiforme Model Workflow
Step 1: Generation of cerebral organoids
Human iPSC-derived cerebral organoids are differentiated to form complex neural tissues containing neurons and glial progenitors.
Step 2: Introduction of GBM cells
Patient-derived GBM cells or stem-like populations are introduced via surface seeding or microinjection.
Step 3: Tumor–brain interaction analysis
GBM invasion, migration patterns, and cellular plasticity are monitored within the organoid matrix.
Discuss Your GBM Research
Impacts
Human-relevant context
Enables GBM research in a human brain–like environmentEnhanced translatability
Improves biological relevance over conventional in vitro modelsAnimal reduction
Reduces reliance on animal models for early-stage investigationBetter decision-making
Supports more informed candidate selection in neuro-oncology research
Your CRO Partner for Human-Relevant Organoid Research & Drug Discovery
Customizable cerebral organoid models for Glioblastoma Multiforme research.
